ImtiazAMalikMD

Oncology • Merced, CA

Hematologic Oncology

Physician

Join to view full profile

Dr. Malik is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Malik's full profile

Already have an account?

Office
3303 M St
Merced, CA 95348
Phone+1 209-388-1600

Fax+1 209-388-1610

Education & Training

University of California (Irvine)Fellowship, Hematology and Medical Oncology, 1983 - 1986
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 1982 - 1983
One Brooklyn Health System/Interfaith Medical CenterResidency, Internal Medicine, 1979 - 1982
King Edward Medical UniversityClass of 1977

Certifications & Licensure

CA State Medical License 1983 - 2027
MT State Medical License 2020 - 2024
TN State Medical License 2021 - 2023
NY State Medical License 1981 - 2002
OH State Medical License 1999 - 2002
PA State Medical License 1982 - 1983
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal Cancer Start of enrollment: 2009 Jul 01
Unknown status
Phase 2

Publications & Presentations

PubMed

36 citations
Axitinib and/or bevacizumab with modified FOLFOX-6 as first-line therapy for metastatic colorectal cancer: a randomized phase 2 study.
Jeffrey R. Infante, Tony R. Reid, Allen Lee Cohn, William Jeffery Edenfield, Terrence P. Cescon
Cancer. 2013-07-15
6 citations
A Phase I Study Of Docetaxel, Oxaliplatin, & Capecitabine (DOC) As First-Line Therapy of Patients With Locally Advanced or Metastatic Adenocarcinoma of Stomach and GE ...
Imtiaz A. Malik, Pedro Bernal, Janet Byrd
Cancer Investigation. 2010-09-14
48 citations
A randomized, placebo-controlled phase ii study evaluating the reduction of neutropenia and febrile neutropenia in patients with colorectal cancer receiving pegfilgras...
J. Randolph Hecht, Madhavan V. Pillai, Russell Gollard, William Heim, Forrest Swan
Clinical Colorectal Cancer. 2010-04-01

Press Mentions

Agrometeorology Section of SKUAST-J Organizes Awareness CampSeptember 26th, 2019

Other Languages

Punjabi